129 related articles for article (PubMed ID: 35577105)
21. FGF21 regulates melanogenesis in alpaca melanocytes via ERK1/2-mediated MITF downregulation.
Wang R; Chen T; Zhao B; Fan R; Ji K; Yu X; Wang X; Dong C
Biochem Biophys Res Commun; 2017 Aug; 490(2):466-471. PubMed ID: 28623131
[TBL] [Abstract][Full Text] [Related]
22. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells.
Rotolo S; Diotti R; Gordon RE; Qiao RF; Yao Z; Phelps RG; Dong J
Int J Cancer; 2005 May; 115(1):164-9. PubMed ID: 15657897
[TBL] [Abstract][Full Text] [Related]
23. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
[TBL] [Abstract][Full Text] [Related]
24. KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
Bagati A; Moparthy S; Fink EE; Bianchi-Smiraglia A; Yun DH; Kolesnikova M; Udartseva OO; Wolff DW; Roll MV; Lipchick BC; Han Z; Kozlova NI; Jowdy P; Berman AE; Box NF; Rodriguez C; Bshara W; Kandel ES; Soengas MS; Paragh G; Nikiforov MA
Oncogene; 2019 May; 38(19):3585-3597. PubMed ID: 30664687
[TBL] [Abstract][Full Text] [Related]
25. Curcumin inhibits melanogenesis in human melanocytes.
Tu CX; Lin M; Lu SS; Qi XY; Zhang RX; Zhang YY
Phytother Res; 2012 Feb; 26(2):174-9. PubMed ID: 21584871
[TBL] [Abstract][Full Text] [Related]
26. Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality.
Dhomen N; Da Rocha Dias S; Hayward R; Ogilvie L; Hedley D; Delmas V; McCarthy A; Henderson D; Springer CJ; Pritchard C; Larue L; Marais R
Pigment Cell Melanoma Res; 2010 Feb; 23(1):112-20. PubMed ID: 20002887
[TBL] [Abstract][Full Text] [Related]
27. BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products.
Hay R; MacRae E; Barber D; Khalil M; Demetrick DJ
Arch Pathol Lab Med; 2007 Sep; 131(9):1361-7. PubMed ID: 17824790
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAF
Ko T; Sharma R; Li S
Oncogene; 2020 Jan; 39(4):723-738. PubMed ID: 31548614
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
[TBL] [Abstract][Full Text] [Related]
31. Additive effect of heat on the UVB-induced tyrosinase activation and melanogenesis via ERK/p38/MITF pathway in human epidermal melanocytes.
Gu WJ; Ma HJ; Zhao G; Yuan XY; Zhang P; Liu W; Ma LJ; Lei XB
Arch Dermatol Res; 2014 Aug; 306(6):583-90. PubMed ID: 24671267
[TBL] [Abstract][Full Text] [Related]
32. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
33. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
[TBL] [Abstract][Full Text] [Related]
34. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
[TBL] [Abstract][Full Text] [Related]
35. Opsin 5 is a key regulator of ultraviolet radiation-induced melanogenesis in human epidermal melanocytes.
Lan Y; Zeng W; Dong X; Lu H
Br J Dermatol; 2021 Aug; 185(2):391-404. PubMed ID: 33400324
[TBL] [Abstract][Full Text] [Related]
36. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
Poulikakos PI; Persaud Y; Janakiraman M; Kong X; Ng C; Moriceau G; Shi H; Atefi M; Titz B; Gabay MT; Salton M; Dahlman KB; Tadi M; Wargo JA; Flaherty KT; Kelley MC; Misteli T; Chapman PB; Sosman JA; Graeber TG; Ribas A; Lo RS; Rosen N; Solit DB
Nature; 2011 Nov; 480(7377):387-90. PubMed ID: 22113612
[TBL] [Abstract][Full Text] [Related]
37. Microtubule-associated protein light chain 3 is involved in melanogenesis via regulation of MITF expression in melanocytes.
Yun WJ; Kim EY; Park JE; Jo SY; Bang SH; Chang EJ; Chang SE
Sci Rep; 2016 Jan; 6():19914. PubMed ID: 26814135
[TBL] [Abstract][Full Text] [Related]
38. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
39. BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.
Friday BB; Yu C; Dy GK; Smith PD; Wang L; Thibodeau SN; Adjei AA
Cancer Res; 2008 Aug; 68(15):6145-53. PubMed ID: 18676837
[TBL] [Abstract][Full Text] [Related]
40. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM
Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]